165 related articles for article (PubMed ID: 6124402)
1. Phenytoin metabolism in mice.
Chow SA; Fischer LJ
Drug Metab Dispos; 1982; 10(2):156-60. PubMed ID: 6124402
[TBL] [Abstract][Full Text] [Related]
2. Biliary excretion of diphenylhydantoin in the rat. Time-course studies.
Inaba T; Umeda T
Drug Metab Dispos; 1975; 3(2):69-73. PubMed ID: 236160
[TBL] [Abstract][Full Text] [Related]
3. Studies of the metabolism of 5,5-diphenylhydantoin relating principally to the stereoselectivity of the hydroxylation reactions in man and the dog.
Butler TC; Dudley KH; Johnson D; Roberts SB
J Pharmacol Exp Ther; 1976 Oct; 199(1):82-92. PubMed ID: 978486
[TBL] [Abstract][Full Text] [Related]
4. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man.
Claesen M; Moustafa MA; Adline J; Vandervorst D; Poupaert JH
Drug Metab Dispos; 1982; 10(6):667-71. PubMed ID: 6130920
[TBL] [Abstract][Full Text] [Related]
5. Determination of 5-(3,4-Dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin (Dihydrodiol) and quantitative studies of phenytoin metabolism in man.
Maguire JH; Kraus BL; Butler TC; Dudley KH
Ther Drug Monit; 1979; 1(3):359-70. PubMed ID: 555579
[TBL] [Abstract][Full Text] [Related]
6. Isoniazid-induced inhibition in the biotransformation of [14C] diphenylhydantoin in rat.
Buttar HS
Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):35-57. PubMed ID: 905633
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective inhibition of diphenylhydantoin metabolism by p-hydroxyphenyl-phenylhydantoin enantiomers in rats.
Huang JD; Hsieh CY
Chirality; 1991; 3(6):454-9. PubMed ID: 1812955
[TBL] [Abstract][Full Text] [Related]
8. Oxygen-18 incorporation studies of the metabolism of phenytoin to the catechol.
Billings RE; Fischer LJ
Drug Metab Dispos; 1985; 13(3):312-7. PubMed ID: 2861989
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in rats in the metabolism of phenytoin to 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin.
Billings RE
J Pharmacol Exp Ther; 1983 Jun; 225(3):630-6. PubMed ID: 6864524
[TBL] [Abstract][Full Text] [Related]
10. Bioactivation of phenytoin by human cytochrome P450: characterization of the mechanism and targets of covalent adduct formation.
Munns AJ; De Voss JJ; Hooper WD; Dickinson RG; Gillam EM
Chem Res Toxicol; 1997 Sep; 10(9):1049-58. PubMed ID: 9305589
[TBL] [Abstract][Full Text] [Related]
11. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
Fritz S; Lindner W; Roots I; Frey BM; Küpfer A
J Pharmacol Exp Ther; 1987 May; 241(2):615-22. PubMed ID: 3572817
[TBL] [Abstract][Full Text] [Related]
12. Hydroxylation of 5,5-diphenylhydantoin (phenytoin) by dog liver microsomes.
Butler TC; Dudley KH; Mitchell GN; Johnson D
Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):4-9. PubMed ID: 21639
[TBL] [Abstract][Full Text] [Related]
13. Phenytoin metabolism in pregnancy.
Kochenour NK; Emery MG; Sawchuk RJ
Obstet Gynecol; 1980 Nov; 56(5):577-82. PubMed ID: 7432728
[TBL] [Abstract][Full Text] [Related]
14. Decreased hepatic 5, 10-methylenetetrahydrofolate reductase activity in mice after chronic phenytoin treatment.
Billings RE
Mol Pharmacol; 1984 May; 25(3):459-66. PubMed ID: 6374425
[TBL] [Abstract][Full Text] [Related]
15. In vivo distribution of carbon-11 phenytoin and its major metabolite, and their use in scintigraphic imaging.
Stavchansky SA; Tilbury RS; McDonald JM; Ting CT; Kostenbauder HB
J Nucl Med; 1978 Aug; 19(8):936-41. PubMed ID: 98619
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of p-hydroxylated and dihydrodiol metabolites of phenytoin in urine by high-performance liquid chromatography.
Szabo GK; Pylilo RJ; Davoudi H; Browne TR
J Chromatogr; 1990 Dec; 535(1-2):279-85. PubMed ID: 2089057
[TBL] [Abstract][Full Text] [Related]
17. Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.
O'Leary TD; Sansom LN
J Pharmacol Exp Ther; 1981 Mar; 216(3):613-6. PubMed ID: 6782238
[TBL] [Abstract][Full Text] [Related]
18. Inhibition and induction of drug biotransformation in vivo by 8-methoxypsoralen: studies of caffeine, phenytoin and hexobarbital metabolism in the rat.
Mays DC; Nawoot S; Hilliard JB; Pacula CM; Gerber N
J Pharmacol Exp Ther; 1987 Oct; 243(1):227-33. PubMed ID: 3668854
[TBL] [Abstract][Full Text] [Related]
19. Effects of diazepam on the biliary excretion of diphenylhydantoin in the rat.
El-Hawari AM; Plaa GL
J Pharmacol Exp Ther; 1977 Apr; 201(1):14-25. PubMed ID: 850136
[TBL] [Abstract][Full Text] [Related]
20. Evidence for an arene-3,4-oxide as a metabolic intermediate in the meta- and para-hydroxylation of phenytoin in the dog.
Moustafa MA; Claesen M; Adline J; Vandervorst D; Poupaert JH
Drug Metab Dispos; 1983; 11(6):574-80. PubMed ID: 6140142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
